AstraZeneca shares slide even as the company\'s coronavirus vaccine trial results show \'promise\'

AstraZeneca shares slide even as the company's coronavirus vaccine trial results show 'promise'

Business Insider Monday, 20 July 2020 ()
AstraZeneca shares slide even as the company's coronavirus vaccine trial results show 'promise'· *AstraZeneca shares slid on Monday despite positive news from the drugmaker's first human COVID-19 vaccine trials.*
· *The early-stage human trial data for the vaccine — which is being developed in conjunction with Oxford University — showed the results of 543 vaccinated volunteers.*
· *The vaccine was able to generate...
0
shares
 
Video Credit: Reuters Studio - Published
News video: Britain signs vaccine deals for 90mln doses

Britain signs vaccine deals for 90mln doses 01:24

 Britain has signed deals to secure 90 million doses of two possible COVID-19 vaccines from the Pfizer and BioNTech alliance and French group Valneva, the business ministry said on Monday. Ciara Lee reports